Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

The conundrum of missing data vs. inter-rater variability.

Decentralized trials (DCTs) have been linked to increased participation rates of people of underserved populations.

Real world data (RWD), which is data from actual patient treatments, provides valuable information on safety and effectiveness of innovative ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

GCCL is committed to customer success, emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research ...

While death rates from cardiovascular disease have declined 60% since 1950, a recent upward trend aligns with increases in ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...